Masimo International Sarl

Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. A key medical technology innovator, Masimo is responsible for the invention of award-winning noninvasive technologies that are revolutionizing patient monitoring, including Masimo SET® pulse oximetry, Masimo rainbow® SET Pulse CO-Oximetry and new Masimo noninvasive and continuous total hemoglobin (SpHb®) monitoring technology. These new rainbow® technologies are expected to open new markets and significantly expand the company’s growth opportunities. Joe Kiani founded Masimo in 1989 as a private "garage start-up" company because he was convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry.

Today, Masimo has grown into a successful publicly traded medical technology company employing over 2,500 people worldwide with product revenues that have increased 4-fold in the last five years. In addition, the company has technology license and OEM agreements with leading patient monitoring manufacturers spanning the globe including Atom, Datascope, GE Medical, Medtronic, Philips, Spacelabs, and Zoll. Masimo is not only the inventor of Measure-through Motion and Low Perfusion pulse oximetry and Pulse CO-Oximetry technologies, but is also the market-leading pulse oximetry technology solution.

In 1995, Masimo debuted Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo SET—a breakthrough in pulse oximetry technology that virtually eliminated false alarms and increased pulse oximetry’s ability to detect life-threatening events. More than 100 independent and objective studies demonstrate that Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion.

In 2005, Masimo introduced rainbow® SET Pulse CO-Oximetry, a breakthrough noninvasive blood constituent monitoring platform that measures many blood constituents that previously required invasive procedures. Masimo rainbow SET continuously and noninvasively measures total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®) and pleth variability index (PVI®), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI), enabling early detection and treatment of potentially life-threatening conditions.

For more than 20 years now, Masimo has been focused on a singular mission to create noninvasive patient monitoring technologies that are more effective and reliable and to improve patient outcomes and reduce the cost of care by bringing these technologies to new sites and applications. The result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making.

Events

Events not available

News

ICU Management

Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter® & Connectivity Hub

2017 20 Mar

Masimo Rad-97™ Pulse CO-Oximeter® and Connectivity Hub with Noninvasive Blood Pressure Masimo (NASDAQ: MASI) has announced the CE marking of noninvasive blood pressure (NIBP) measurements for the Rad-97™ Pulse CO-Oximeter® and connectivity hub. Rad-97 offers Measure-through Motion and Low Perfusion™ SET® pulse oximetry and upgradeable rainbow® noninvasive... Read more

ICU Management

New Study Evaluates the Utility of Masimo SpHb® Monitoring During Liver Transplantation

2017 19 Mar

Masimo (NASDAQ: MASI) has announced the publication of a recent study conducted on adult patients undergoing liver transplantation (LT), in which researchers assessed the accuracy and trending ability of noninvasive Masimo SpHb® (total hemoglobin) measurement, as compared to conventional laboratory hemoglobin (HbL) measurements. The researchers found... Read more

ICU Management

Masimo Announces Availability of the RD SedLine® Adult EEG Sensor

2017 07 Mar

Masimo (NASDAQ: MASI) has announced availability of the RD SedLine® EEG sensor, for use with Masimo SedLine Brain Function Monitoring and compatible with simultaneous use of Masimo O3™ Regional Oximetry. SedLine and O3 provide simultaneous monitoring on the Masimo Root® monitoring platform, helping to give clinicians more information about the brain.The... Read more

ICU Management

New Study Assesses the Utility of Masimo PVi® Monitoring During Colorectal Surgery

2017 27 Feb

Masimo (NASDAQ: MASI) has announced the findings of a recent study conducted on low-risk patients undergoing colorectal surgery, in which researchers assessed the utility of noninvasive and continuous Masimo PVi® (Pleth Variability Index) monitoring to guide fluid management, as compared to esophageal Doppler, an invasive method. The researchers found... Read more

ICU Management

Masimo Announces Recent Study Monitoring Methemoglobin Levels

2017 26 Feb

Masimo (NASDAQ: MASI) has announced the findings of a recent study conducted on children admitted to a Ugandan hospital with fever and malaria, in which Masimo’s noninvasive measurement SpMet® was used to monitor methemoglobin (MetHb) levels. One group of children with severe malaria was selected to receive inhaled nitric oxide (iNO) treatment as an... Read more

ICU Management

Masimo Announces the Addition of Early Warning Score to the Root® Patient Monitoring Platform

2017 02 Feb

Masimo (NASDAQ: MASI) announced today the limited market release of Early Warning Score (EWS) on the Root® patient monitoring and connectivity platform. EWS aggregates information from multiple vital signs and clinical observations to generate a score that represents the potential degree of patient deterioration.Root, which works in conjunction with... Read more

ICU Management

Masimo Announces FDA 510(k) Clearance for TFA-1TM Single-Patient-Use Forehead Senso

2016 19 Dec

Masimo (NASDAQ:MASI) announced today FDA 510(k) clearance for the TFA-1™ Single-Patient-Use Adhesive Forehead Sensor. This single-patient-use sensor allows clinicians to monitor patients using Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry from an alternative monitoring site, the forehead, rather than a finger.Masimo TFA-1 Single-Patient-Use... Read more

ICU Management

Masimo Receives Gates Foundation Grant to Develop Combined Pneumonia-Screening Device

2016 13 Nov

Masimo (NASDAQ: MASI) has announced, in advance of World Pneumonia Day tomorrow, that it has received a grant of $4.95 million from the Bill & Melinda Gates Foundation (BMGF). The grant will support Masimo’s efforts to develop a low-cost pulse oximeter for use in pneumonia screening in several low-resource areas outside the U.S. While still in development,... Read more

ICU Management

Philips & Masimo Sign Multi-Year Agreement in Patient Monitoring & Select Therapy Solutions

2016 07 Nov

Multi-year business partnership combines Masimo’s expertise in non-invasive sensor and signal processing technologies and Philips’ expertise in integrated patient monitoring and therapy solutionsBusiness partnership involves technology integration and marketing and sales cooperation in North America and certain markets in Asia and EuropeAgreement ends... Read more

ICU Management

Adam Mikkelson of Camber Capital Management Joins Masimo’s Board of Directors

2016 28 Oct

Masimo (NASDAQ: MASI), a global innovator of noninvasive patient monitoring technologies, announced today that Adam Mikkelson, Partner at Camber Capital Management, LLC, has been elected to Masimo’s Board of Directors.Mr. Mikkelson has been with Camber Capital Management, a healthcare-focused investment fund, since 2007. He has almost 15 years of experience... Read more

ICU Management

Study Investigates the Impact of Masimo Continuous SpHb® and PVI® on Anesthesia-Related Mortality

2016 24 Oct

Masimo (NASDAQ: MASI) has announced the findings of an abstract presented at the American Society of Anesthesiologists’ (ASA) Annual Meeting in Chicago. In the study, researchers at Hôpital Dupuytren, part of the Centre Hospitalier Universitaire of Limoges, France (CHU Limoges), investigated the clinical utility of noninvasive, continuous hemoglobin... Read more

ICU Management

WFSA Signs Commitment to Support Patient Safety Movement’s Mission of Zero Patient Deaths by 2020

2016 19 Oct

Patient Safety Movement Foundation Joins WFSA’s SAFE-T CampaignThe World Federation of Societies of Anaesthesiologists (WFSA) has signed a commitment to action and announced that it will support the Patient Safety Movement Foundation (PSMF) and its mission to eliminate preventable deaths by the year 2020. Concurrently, the PSMF is joining the WFSA’s... Read more

ICU Management

Masimo Partners with Smile Train to Advance Safe Surgery

2016 30 Sep

Masimo (NASDAQ: MASI) has announced that it is partnering with Smile Train to help ensure the safety of patients undergoing cleft lip and/or palate surgery in low-resource settings around the world.Patient monitoring, including the use of pulse oximetry, is a key part of ensuring safe surgical care; however, in lower-resource settings essential monitoring... Read more

ICU Management

Masimo Announces a Special Worldwide Program for SpHb® Monitoring for Zika Virus Affected Areas

2016 29 Sep

Masimo (NASDAQ: MASI) has announced that in response to the Zika virus and its potential impact on the availability of blood products, Masimo is creating a special program to dramatically reduce the cost of and increase access to Masimo’s continuous hemoglobin monitoring (SpHb®) solutions, shown to help clinicians reduce blood transfusions in both low... Read more

ICU Management

Masimo Announces Four-Year Partnership with World Federation of Societies of Anaesthesiologists

2016 29 Sep

Joint Initiative, “Safe Anaesthesia – ASAP,” Is to Improve Anesthesia Care in Low Resource CountriesMasimo (NASDAQ: MASI) has announced at the World Congress of Anaesthesiologists (WCA) in Hong Kong that it has become the first Global Impact Partner of the World Federation of Societies of Anaesthesiologists (WFSA). The four-year partnership, “Safe Anaesthesia... Read more

ICU Management

Study on Abdominal Surgical Patients Investigates Clinical Utility of Masimo PVI®

2016 15 Sep

Masimo (NASDAQ: MASI) has announced the findings of a study recently presented at the World Congress of Anesthesiologists (WCA) in Hong Kong. In the study, researchers at Cairo University in Egypt investigated the clinical utility of a Masimo SET® noninvasive, continuous measurement, PVI®.In the prospective study of 60 adult patients undergoing major... Read more

ICU Management

Noninvasive Hemoglobin Monitoring Using Masimo SpHb® May Reduce Red Blood Cell Transfusion

2016 09 Sep

 Masimo (NASDAQ: MASI) has announced that in a new study recently presented at the World Congress of Anesthesiologists (WCA) in Hong Kong, researchers concluded that continuous and noninvasive hemoglobin monitoring using Masimo SpHb® may reduce excessive intraoperative red blood cell (RBC) transfusion.1In a retrospective review of 371 patients who underwent... Read more

ICU Management

Masimo Announces CE Marking for Pediatric O3™ Regional Oximetry

2016 04 Aug

Masimo (NASDAQ: MASI) has announced the CE marking for the pediatric indication for O3™ regional oximetry with the O3 pediatric sensor. Regional oximetry, also referred to as tissue or cerebral oximetry, helps clinicians monitor cerebral oxygenation.O3 regional oximetry uses near-infrared spectroscopy (NIRS) to continuously monitor absolute and trended... Read more

ICU Management

Ohio Critical Access Hospital Adopts Masimo Root® with Radius-7®, Radical-7®,& Patient SafetyNet™

2016 28 Jul

Masimo (NASDAQ: MASI) has announced that University Hospitals Geneva Medical Center (UH Geneva), a Critical Access Hospital in Geneva, Ohio, is building a hospital-wide wireless monitoring and clinician notification system using Masimo Patient SafetyNet™* in conjunction with Masimo Root® with Radius-7® and Masimo Radical-7®. UH Geneva is part of University... Read more

ICU Management

New Study Evaluates Masimo PVI® as a Predictor of Fluid Responsiveness

2016 28 Jul

Masimo (NASDAQ: MASI) has announced that a new study of patients undergoing liver transplantation evaluated the relationship of PVI® to right ventricular end-diastolic volume (RVEDVI) and concluded that PVI provided a “reliable estimate of [cardiac] preload status and may be a useful predictor of fluid responsiveness.”1 PVI measures the dynamic changes... Read more

ICU Management

New Study Assesses Utility of 1st Generation Masimo Pronto® Pulse CO-Oximeter® with SpHb® Spot

2016 15 Jul

Masimo (NASDAQ: MASI) has announced that in a new study using the 1st Generation Masimo Pronto® Pulse CO-Oximeter®, which noninvasively measures total hemoglobin (SpHb®), researchers found that noninvasive and invasive measurements correlated well and that “[g]iven the rapid availability of results and the lack of requirement of venipuncture, noninvasive... Read more

ICU Management

DHZB Adopts Masimo’s SedLine® Brain Function Monitoring & O3™ Regional Oximetry

2016 08 Jul

Masimo (NASDAQ: MASI) has announced  that Deutsches Herzzentrum Berlin (DHZB / German Heart Center Berlin) in Berlin, Germany, has adopted Masimo’s SedLine® Brain Function Monitoring and O3™ Regional Oximetry technologies to monitor patients in the operating room and intensive care unit.“Our non-profit hospital performs over 32,000 treatments each year.... Read more

ICU Management

Masimo Announces FDA 510(k) Clearance for Radius-7® with rainbow® Technology

2016 28 Jun

Radius-7 is the First Wearable, Tetherless, Noninvasive rainbow® Monitor Masimo (NASDAQ: MASI) has announced FDA 510(k) clearance for Radius-7® – the first and only wearable, tetherless, noninvasive rainbow® monitor. Radius-7, which connects to the Root® patient monitoring and connectivity platform, is now available in the U.S. with breakthrough Masimo... Read more

ICU Management

New SunTech Medical CT40 Vital Signs Device to Feature Masimo SET® Pulse Oximetry Technology

2016 23 Jun

Masimo (NASDAQ: MASI) and SunTech Medical, a Halma (LSE:HLMA) company, jointly has announced the integration of Masimo SET® pulse oximetry technology into SunTech’s CT40, a next generation spot-check vital signs device.Masimo Signal Extraction Technology (SET®) Measure-through Motion and Low Perfusion™ pulse oximetry measures oxygen saturation (SpO2),... Read more

ICU Management

Masimo Announces 510(k) Clearance for O3™ Regional Oximetry

2016 13 Jun

Masimo (NASDAQ: MASI) has announced FDA 510(k) clearance for O3™ regional oximetry. Regional oximetry, also referred to as tissue or cerebral oximetry, may help clinicians monitor cerebral oxygenation in situations in which pulse oximetry alone may not be fully indicative of the oxygen in the brain due to various factors, such as the type of clinical... Read more

ICU Management

Masimo Announces Full Market Release of Next Generation SpHb® Spot Check Pronto®

2016 08 Jun

Masimo (NASDAQ: MASI) has announced the full market release outside the U.S. of the Pronto® Pulse CO-Oximeter® with Next Generation SpHb® Spot Check technology. Next Generation Pronto features rainbow SET™ technology, for noninvasive spot checking of total hemoglobin (SpHb), oxygen saturation (SpO2), pulse rate (PR), and perfusion index (PI).In addition... Read more

ICU Management

ESA Partners with Patient Safety Movement to Lead the Movement to Zero Preventable Deaths in Europe

2016 06 Jun

The European Society of Anaesthesiology (ESA) and the Patient Safety Movement Foundation has announced that on May 28, 2016 at the annual congress Euroanaesthesia 2016 in London, the ESA made a public commitment to lead the Patient Safety Movement in over 50 countries in Europe.“As clinicians, our number one focus is Patient Safety,” said Dr. Zeev Goldik,... Read more

ICU Management

India’s Motherhood Hospitals, Standardizes on Masimo SET® Technology

2016 02 Jun

Masimo (NASDAQ: MASI) has announced that Motherhood Hospitals, a maternal care specialist with five hospitals in three cities in India, has standardized on Masimo SET® (Signal Extraction Technology) pulse oximetry at all locations. Motherhood Hospitals will also be screening for Critical Congenital Heart Disease (CCHD) using Masimo’s technology.“We... Read more

ICU Management

Masimo to Showcase Next Generation SedLine® Brain Function Monitor at 2016 Euroanaesthesia Congress

2016 27 May

SedLine, Which Helps Clinicians Improve Anesthetic Management, Receives CE MarkMasimo (NASDAQ: MASI) announced today the CE mark and scheduled full market release of Next Generation SedLine® Brain Function Monitoring technology at the European Society of Anaesthesiology's (ESA) 2016 Euroanaesthesia Congress in London, England.Next Generation SedLine... Read more

ICU Management

Two Fire Departments Honored for Excellence in Emergency Medical Services

2016 19 May

Fire-Service Based EMS Awards Presented at 28th Annual National Fire and Emergency Services DinnerThe Congressional Fire Services Institute (CFSI) and Masimo (NASDAQ: MASI) honored two fire departments for best practices and innovative solutions in the delivery of emergency medical services with the Excellence in Fire Service-Based EMS Award. The award... Read more

ICU Management

Masimo Reports First Quarter 2016 Financial Results

2016 09 May

Q1 2016 Highlights (compared to Q1 2015):Total revenue, including royalties, rose 10.8% to $171.2 millionProduct revenue rose 10.8% to $163.3 millionMasimo rainbow® revenue rose 39.2% to $16.9 millionSET® and rainbow® SET® units shipments were 46,300GAAP net income of $27.6 million, or $0.53 per diluted share versus $20.5 million, or $0.38 per diluted... Read more

ICU Management

France’s University Hospitals Adopts Masimo Radical-7®,Including SpHb®,PVI®,& SET® Pulse Oximetry

2016 21 Apr

Masimo(NASDAQ: MASI) has announced that Centre Hospitalier Universitaire (CHU) de Limoges, in Limoges, France has installed Masimo’s Radical-7®, including noninvasive, continuous hemoglobin (SpHb®), Pleth Variability Index (PVI®), and SET® pulse oximetry technology, to monitor surgical patients and critical patients in the post-anesthesia care unit... Read more

ICU Management

Study on Relationship Between Masimo’s ORI™& Arterial Partial Pressure of Oxygen During Surgery

2016 31 Mar

Masimo (NASDAQ: MASI) has announced that a new retrospective study reports the relationship between Masimo’s Oxygen Reserve Index (ORI™) and arterial partial pressure of oxygen (PaO2) during surgery. The study suggests that ORI may provide an advanced indication of impending desaturation in adults undergoing surgery based on trends in the relationship... Read more

ICU Management

Accuracy of Masimo’s Blue®Sensors at Saturations below 85% in Children with Cyanotic CHD

2016 22 Mar

Masimo (NASDAQ: MASI) has announced that a new study reported on the accuracy of Masimo’s Blue® sensors as compared to Nellcor and Masimo Standard sensors for cyanotic children with blood oxygen saturation less than 85%.1 Masimo’s Blue sensor was designed specifically for cyanotic infants and children with congenital heart disease.The study was performed... Read more

ICU Management

Masimo Introduces SafetyNet™ Surveillance at HIMSS16

2016 07 Mar

Patient Video Surveillance System Provides High-Definition Real-Time Imaging at the BedsideMasimo (NASDAQ: MASI) has announced the debut of SafetyNet™Surveillance at the HIMSS (Healthcare Information and Management Systems Society) 2016 Annual Conference and Exhibition in Las Vegas.SafetyNet Surveillance is a video surveillance system that provides... Read more

ICU Management

Masimo Announces Iris™ Gateway at HIMSS16

2016 07 Mar

Integrated Medical Device Data Management Solution Designed to Fill the Gaps in Electronic Medical RecordsMasimo (NASDAQ: MASI) has announced the debut of Iris™ Gateway, a server-based software solution for integrating medical device data, at the HIMSS (Healthcare Information and Management Systems Society) 2016 Annual Conference and Exhibition in Las... Read more

ICU Management

Manipal Hospitals is the First in India to Adopt Masimo Patient SafetyNet™

2016 07 Mar

Masimo (NASDAQ: MASI) has announced that Manipal Hospitals is the first hospital in India to install Masimo Patient SafetyNet™, a remote monitoring and clinician notification system."With Patient SafetyNet, we are now able to monitor a certain set of patients 24x7," said Gopal Devanahalli, Chief Operating Officer of Manipal Hospitals. "One of the key... Read more

ICU Management

Masimo Announces FDA 510(k) Clearance for Root® with Noninvasive Blood Pressure and Temperature

2016 07 Mar

Masimo (NASDAQ: MASI) announced today FDA 510(k) clearance for noninvasive blood pressure and temperature measurements for the Root® patient monitoring and connectivity platform.Root with noninvasive blood pressure from SunTech Medical enables clinicians to measure arterial blood pressure for adult, pediatric, and neonatal patients, with three distinct... Read more

ICU Management

Masimo's rainbow® Acoustic Monitoring was Associated with Fewer Alarm Events in New Clinical Study

2016 24 Feb

For Breath Rates Less Than or Equal to 4 Breaths Per Minute, RAM Showed 78% True Positives and 22% False Positives, While Capnography Showed 30% True Positives and 70% False PositivesMasimo (NASDAQ: MASI) has announced that Masimo's rainbow®Acoustic Monitoring (RAM™) was associated with fewer alarm events during planned moderate sedation in a new clinical... Read more

Jobs not available

Catalogue

    Catalogue not available

******@***masimo.com
Puits Godet, 10,
Neuchatel
2000
Switzerland
+41 32 7201159

White Papers - Case Studies

Not available

Videos

    Videos not available

Articles

Not available